1. Home/
  2. Compounds/
  3. selumetinib:decitabine (4:1 mol/mol)

selumetinib:decitabine (4:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:decitabine (4:1 mol/mol)
PharmacoGx selumetinib:decitabine (4:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:decitabine (4:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA RAB23 CTRPv2 pan-cancer AAC -0.2 2e-07
mRNA STX11 CTRPv2 pan-cancer AAC -0.18 3e-07
mRNA BEND6 CTRPv2 pan-cancer AAC -0.19 3e-07
mRNA FERMT1 CTRPv2 pan-cancer AAC 0.21 3e-07
mRNA NRROS CTRPv2 pan-cancer AAC 0.22 4e-07
mRNA GSDMA CTRPv2 pan-cancer AAC 0.17 4e-07
mRNA ZBTB32 CTRPv2 pan-cancer AAC -0.17 4e-07
mRNA EPHA1 CTRPv2 pan-cancer AAC 0.2 4e-07
mRNA RP11-156P1.2 CTRPv2 pan-cancer AAC -0.18 4e-07
mRNA BAHCC1 CTRPv2 pan-cancer AAC 0.17 4e-07
Download CSV